Table 1.
Patient Characteristics
| Characteristic | No. of Patients | % |
|---|---|---|
| Sex | ||
| Male | 22 | 56.4 |
| Female | 17 | 43.6 |
| Age, years | ||
| Median | 62 | |
| Range | 42-84 | |
| Tumor histology | ||
| Colorectal cancer | 14 | 35.9 |
| Melanoma | 10 | 25.6 |
| Prostate cancer | 8 | 20.5 |
| NSCLC | 6 | 15.4 |
| Renal cell carcinoma | 1 | 2.6 |
| ECOG PS | ||
| 0 | 13 | 33.3 |
| 1 | 26 | 66.7 |
| Prior therapies | ||
| Median | 4 | |
| Range | 1-13 | |
| Chemotherapy* | 36 | 92.3 |
| Radiation therapy | 13 | 33.3 |
| Surgery | 39 | 100 |
| Immunotherapy | 14 | 35.9 |
| Biologics† | 26 | 66.7 |
| Hormonal therapy | 8 | 20.5 |
Abbreviations: NSCLC, non–small-cell lung cancer; ECOG, Eastern Cooperative Oncology Group; PS, performance status.
*
Includes molecularly targeted therapies.
†
Includes monoclonal antibody therapies.